Inventor · disambiguated record
Anna Slager
Also filed as: SLAGER ANNA · SLAGER ANNA M · SLAGER ANNA MARIA
12 granted patents·9 pending applications·1 citations·filing 2008–2025
82Inventor score
Top patents by PatentIndex Score
21 records- 0180US12064473B2Cancer vaccines targeting Survivin and uses thereofINOVIO PHARMACEUTICALS INC·Filed 2018·Granted Aug 20, 2024·1 cites·2 claims
- 0279US2025057929A1Cancer vaccines targeting boris and uses thereofINOVIO PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0378US2024285741A1Cancer vaccines targeting mesothelin and uses thereofINOVIO PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0476US12478667B2Vaccines for recurrent respiratory papillomatosis and methods of using the sameINOVIO PHARMACEUTICALS INC·Filed 2023·Granted Nov 25, 2025·0 cites·36 claims
- 0574US2024358809A1Cancer vaccines targeting survivin and uses thereofINOVIO PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0673US11986517B2Cancer vaccines targeting mesothelin and uses thereofINOVIO PHARMACEUTICALS INC·Filed 2021·Granted May 21, 2024·0 cites·3 claims
- 0772US12161706B2Cancer vaccines targeting BORIS and uses thereofINOVIO PHARMACEUTICALS INC·Filed 2021·Granted Dec 10, 2024·0 cites·3 claims
- 0871US12285473B2Cancer vaccines targeting MUC16 and uses thereofINOVIO PHARMACEUTICALS INC·Filed 2021·Granted Apr 29, 2025·0 cites·16 claims
- 0971US2024115680A1Optimized Synthetic Consensus Immunogenic Compositions Targeting the Follicle Stimulating Hormone Receptor (FSHR)UNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 1071US2025222086A1Cancer vaccines targeting muc16 and uses thereofINOVIO PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1170US11744885B2Vaccines for recurrent respiratory papillomatosis and methods of using the sameINOVIO PHARMACEUTICALS INC·Filed 2021·Granted Sep 5, 2023·0 cites·35 claims
- 1269US11235044B2Cancer vaccines targeting MUC16 and uses thereofINOVIO PHARMACEUTICALS INC·Filed 2018·Granted Feb 1, 2022·0 cites·9 claims
- 1369US11154602B2Cancer vaccines targeting mesothelin and uses thereofINOVIO PHARMACEUTICALS INC·Filed 2018·Granted Oct 26, 2021·0 cites·20 claims
- 1469US11154601B2Cancer vaccines targeting BORIS and uses thereofINOVIO PHARMACEUTICALS INC·Filed 2018·Granted Oct 26, 2021·0 cites·16 claims
- 1567US2022265801A1Cancer Vaccines Targeting PRAME and Uses ThereofINOVIO PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1666US2022265800A1Cancer vaccines targeting lemd1 and uses thereofINOVIO PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1765US11338029B2Cancer vaccines targeting PRAME and uses thereofINOVIO PHARMACEUTICALS INC·Filed 2018·Granted May 24, 2022·0 cites·19 claims
- 1865US2024123052A1Vaccines For Recurrent Respiratory Papillomatosis And Methods of Using the SameINOVIO PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1963US11865166B2Nucleic acid encoding optimized immunogenic peptide that targets follicle stimulating hormone receptorUNIV PENNSYLVANIA·Filed 2017·Granted Jan 9, 2024·0 cites·12 claims
- 2062US11338028B2Cancer vaccines targeting LEMD1 and uses thereofINOVIO PHARMACEUTICALS INC·Filed 2018·Granted May 24, 2022·0 cites·20 claims
- 2148US2009142763A1Nested pcr-based method for specific genotyping of the fc gamma receptor iiia geneWYETH CORP·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anna Slager files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →